BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Dermapharm Holding SE Increases Revenue and Exceeds EBITDA Guidance Dividend Proposal EBITDA Growth Healthcare Products Branded Pharmaceuticals Dermapharm Revenue
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Dermapharm Holding SE augmente son chiffre d'affaires et dépasse les prévisions d'EBITDA Proposition De Dividende Produits De Santé Croissance De L'EBITDA Produits Pharmaceutiques De Marque Chiffre D'affaires De Dermapharm
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Steyr Motors Secures Brazilian Framework Agreement, Boosting Order Backlog Global Expansion Order Backlog Defense Market Steyr Motors Brazil Agreement
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Steyr Motors obtient un accord-cadre au Brésil, augmentant ainsi son carnet de commandes Expansion Mondiale Carnet De Commandes Marché De La Défense Moteurs Steyr Accord Du Brésil
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Kasper Rørsted Joins Circus SE as Advisor Circus SE Food Service Industry Board Of Advisors AI And Robotics Kasper Rørsted
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Kasper Rørsted rejoint Circus SE en tant que conseiller Conseil Consultatif Industrie De La Restauration Cirque SE IA Et Robotique Kasper Rørsted
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Lenzing Group Shows Signs of Recovery in 2024 Market Strategy EBITDA Growth Lenzing 2024 Financials Fiber Sales
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Le groupe Lenzing montre des signes de reprise en 2024 Stratégie De Marché Lenzing Croissance De L'EBITDA Résultats Financiers 2024 Ventes De Fibres
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Sensorion : Bilan 2024 et Perspectives pour 2025 Résultats Financiers Investissements Thérapies Géniques SENS-401 SENS-501
BRIEF published on 03/14/2025 at 07:35, 1 year 3 months ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
Published on 06/30/2026 at 09:01, 1 hour 30 minutes ago Apex Mobilizes Drill Rig and Commences 2026 Exploration Program at the Cap Critical Minerals Project
Published on 06/30/2026 at 08:05, 2 hours 26 minutes ago Notice of Annual and Special Meeting of Shareholders
Published on 06/30/2026 at 02:00, 8 hours 31 minutes ago MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 10:05, 26 minutes ago dss+ Named One of Switzerland's 'Best Managed Companies' for Third Consecutive Year
Published on 06/30/2026 at 10:00, 31 minutes ago smartbax secures additional financing to advance lead antibiotic program to IND filing
Published on 06/30/2026 at 10:00, 31 minutes ago Invitation to the Conference Call for Investors, Analysts and Media
Published on 06/30/2026 at 09:55, 36 minutes ago Jolywood Debuts Namic Technology in Europe, Shines at Intersolar Europe 2026
Published on 06/30/2026 at 09:46, 45 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 06/30/2026 at 07:30, 3 hours 1 minute ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 3 hours 1 minute ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Published on 06/30/2026 at 07:00, 3 hours 31 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
